Sign in / Join Now
ETFs & Funds
TH-302 in pancreatic
extremely low. Tarceva, approved for panc
+0.4 mos! Cannot get much lower
If shows >0.5 mos (15 day!) improvement on
, may have a chance at FDA approval. Already showed 2 mos improvement in
It is quite amazing that the FDA approved a $50K/yr tx for a 12 day survival benefit. Large pharma sure knows how to work the system
I really hope they aprrove it my dad died from Pancreatic cancer!!!
Add a reply...
Latest StockTalks »
people get THLD breaking news and analysis by email alert.
Get email alerts on THLD »
Threshold Pharmaceuticals, Inc.
Get latest price
From other sites
Threshold Pharmaceuticals Announces Presentation And Webcast At The Stifel Healthcare Conference 2016
at TheStreet (Nov 15, 2016)
Threshold Pharmaceuticals Reports Third Quarter Financial Results
at TheStreet (Nov 7, 2016)
Caris Life Sciences And Threshold Pharmaceuticals Collaborate To Utilize Caris' ADAPT Biotargeting System In The Development Program For Evofosfamide
at TheStreet (Oct 25, 2016)
Is Threshold Pharmaceuticals a Buy? (THLD)
at Investopedia (Oct 3, 2016)
Mid-Day Market Update: Dow Surges Over 150 Points; Threshold Pharmaceuticals Shares Slide
at Benzinga (Sep 30, 2016)